{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:35:39Z","timestamp":1791513339441,"version":"4.3.4"},"reference-count":327,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.semcancer.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:17:49Z","timestamp":1772151469000},"page":"1-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Obesity, type 2 diabetes and cancers of the digestive system"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9494-6571","authenticated-orcid":false,"given":"Simona","family":"Cernea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Cri\u015fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina-Mihaela","family":"L\u0103c\u0103tu\u015fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana Patricia","family":"Zaharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiya","family":"Gancheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2026.02.003_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1161521","article-title":"Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments","volume":"14","author":"Ruze","year":"2023","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, diabetes, and increased cancer progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.semcancer.2026.02.003_bib3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib4","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa628","article-title":"Are the different diabetes subgroups correlated with all-cause, cancer-related, and cardiovascular-related mortality?","volume":"105","author":"Li","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2026.02.003_bib5","article-title":"Obesity, diabetes, and cancer: epidemiology, pathophysiology, and potential interventions","volume":"67","author":"de Andrade Mesquita","year":"2023","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2026.02.003_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.615375","article-title":"Obesity, type 2 diabetes, and cancer risk","volume":"10","author":"Scully","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/jgh.14917","article-title":"Cumulative evidence for the relationship between body mass index and the risk of esophageal cancer: An updated meta-analysis with evidence from 25 observational studies","volume":"35","author":"Tian","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/annonc\/mds244","article-title":"A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma","volume":"24","author":"Turati","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1158\/1055-9965.EPI-05-0860","article-title":"Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis","volume":"15","author":"Kubo","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib10","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160474","article-title":"Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies","volume":"37","author":"Du","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.semcancer.2026.02.003_bib11","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.cgh.2013.05.009","article-title":"Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/a-1145-3500","article-title":"Prevalence of Barrett's esophagus in obese patients undergoing pre-bariatric surgery evaluation: a systematic review and meta-analysis","volume":"52","author":"Qumseya","year":"2020","journal-title":"Endoscopy"},{"key":"10.1016\/j.semcancer.2026.02.003_bib13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/ijms22031253","article-title":"Sex Differences in the Incidence of Obesity-Related Gastrointestinal Cancer","volume":"22","author":"Heo","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jjco\/hyu082","article-title":"Body mass index and risk of gastric cancer: a meta-analysis","volume":"44","author":"Lin","year":"2014","journal-title":"Jpn J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1158\/1055-9965.EPI-13-0042","article-title":"Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies","volume":"22","author":"Chen","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib16","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.ejca.2009.04.019","article-title":"Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies","volume":"45","author":"Yang","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4143\/crt.2019.241","article-title":"Body Mass Index and Risk of Gastric Cancer in Asian Adults: A Meta-Epidemiological Meta-Analysis of Population-Based Cohort Studies","volume":"52","author":"Bae","year":"2020","journal-title":"Cancer Res Treat."},{"issue":"8","key":"10.1016\/j.semcancer.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/cas.13292","article-title":"Body mass index and risk of gastric cancer: A 30-year follow-up study in the Linxian general population trial cohort","volume":"108","author":"Fan","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib19","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/obr.12705","article-title":"Body fatness at a young age and risks of eight types of cancer: systematic review and meta-analysis of observational studies","volume":"19","author":"Hidayat","year":"2018","journal-title":"Obes. Rev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib20","first-page":"263","article-title":"Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies","volume":"23","author":"Huang","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2026.02.003_bib21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/MEG.0b013e32834b8d73","article-title":"Diabetes mellitus and risk of gastric cancer: a systematic review and meta-analysis of observational studies","volume":"23","author":"Ge","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3748\/wjg.v19.i6.936","article-title":"Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis","volume":"19","author":"Yoon","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib23","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.3748\/wjg.v19.i40.6902","article-title":"Diabetes mellitus carries a risk of gastric cancer: a meta-analysis","volume":"19","author":"Shimoyama","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib24","doi-asserted-by":"crossref","first-page":"44881","DOI":"10.18632\/oncotarget.16487","article-title":"Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies","volume":"8","author":"Miao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.02.003_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109866","article-title":"Relationship between diabetes and risk of gastric cancer: A systematic review and meta-analysis of cohort studies","volume":"187","author":"Guo","year":"2022","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.semcancer.2026.02.003_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/CEJ.0000000000000703","article-title":"The association between diabetes and gastric cancer: results from the Stomach Cancer Pooling Project Consortium","volume":"31","author":"Dabo","year":"2022","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib27","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.31557\/APJCP.2022.23.5.1523","article-title":"Diabetes History and Gastric Cancer Risk: Different Results by Types of Follow-Up Studies","volume":"23","author":"Bae","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.13561","article-title":"Diabetes and gastric cancer incidence and mortality in the Asia Cohort Consortium: A pooled analysis of more than a half million participants","volume":"16","author":"De la Torre","year":"2024","journal-title":"J. Diabetes"},{"key":"10.1016\/j.semcancer.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2337\/dc20-0204","article-title":"Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 Cohorts Comprising 32 Million People","volume":"43","author":"Ling","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semcancer.2026.02.003_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.numecd.2020.09.023","article-title":"Risk of cancer incidence and mortality associated with diabetes: a systematic review with trend analysis of 203 cohorts","volume":"31","author":"Ling","year":"2021","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"10.1016\/j.semcancer.2026.02.003_bib31","article-title":"Association between prediabetes and the incidence of gastric cancer: A meta-analysis","volume":"103","author":"Wang","year":"2024","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.semcancer.2026.02.003_bib32","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1158\/1055-9965.EPI-07-0708","article-title":"Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events","volume":"16","author":"Moghaddam","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1467-789X.2009.00613.x","article-title":"A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies","volume":"11","author":"Ning","year":"2010","journal-title":"Obes. Rev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib34","article-title":"Obesity and risk of colorectal cancer: a systematic review of prospective studies","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.02.003_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/bjc.2016.188","article-title":"Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer","volume":"115","author":"Jarvis","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/1751-2980.13130","article-title":"Associations between potential causal factors and colorectal cancer risk: A systematic review and meta-analysis of Mendelian randomization studies","volume":"23","author":"Deng","year":"2022","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.semcancer.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1080\/01635581.2020.1804951","article-title":"Excessive Body Fat at a Young Age Increases the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis","volume":"73","author":"Lei","year":"2021","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib38","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2217\/fon-2023-0165","article-title":"Risk factors for advanced colorectal neoplasm in young adults: a meta-analysis","volume":"19","author":"Ye","year":"2023","journal-title":"Future Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.14309\/ajg.0000000000001393","article-title":"Association of body mass index with risk of early-onset colorectal cancer: systematic review and meta-analysis","volume":"116","author":"Li","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib40","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cgh.2021.01.037","article-title":"Risk factors for early-onset colorectal cancer: a systematic review and meta-analysis","volume":"20","author":"O'Sullivan","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ijc.31100","article-title":"Body fatness at an early age and risk of colorectal cancer","volume":"142","author":"Hidayat","year":"2018","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12916-022-02702-9","article-title":"Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study","volume":"21","author":"Papadimitriou","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.semcancer.2026.02.003_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/obr.12286","article-title":"Body weight gain and risk of colorectal cancer: a systematic review and meta-analysis of observational studies","volume":"16","author":"Schlesinger","year":"2015","journal-title":"Obes. Rev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib44","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170945","article-title":"Abdominal obesity and colorectal cancer risk: systematic review and meta-analysis of prospective studies","volume":"37","author":"Dong","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.semcancer.2026.02.003_bib45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/ajcn\/86.3.556","article-title":"Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies","volume":"86","author":"Larsson","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.semcancer.2026.02.003_bib46","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.3748\/wjg.v13.i31.4199","article-title":"Obesity and colorectal cancer risk: a meta-analysis of cohort studies","volume":"13","author":"Dai","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib47","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1463-1318.2009.01766.x","article-title":"C-CLEAR group. Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index","volume":"11","author":"Harriss","year":"2009","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.semcancer.2026.02.003_bib48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/CEJ.0000000000000231","article-title":"Body mass index and the risk of cancer in women compared with men: a meta-analysis of prospective cohort studies","volume":"26","author":"Xue","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib49","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/ajg.2011.301","article-title":"Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?","volume":"106","author":"Yuhara","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib50","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/s10620-012-2055-1","article-title":"Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis","volume":"57","author":"Deng","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib51","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s10620-012-2059-x","article-title":"Diabetes mellitus is an independent risk factor for colorectal cancer","volume":"57","author":"Sun","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/dia.2012.0263","article-title":"Diabetes mellitus and the occurrence of colorectal cancer: an updated meta-analysis of cohort studies","volume":"15","author":"Wu","year":"2013","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.semcancer.2026.02.003_bib53","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/bjs.9229","article-title":"Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer","volume":"100","author":"De Bruijn","year":"2013","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.semcancer.2026.02.003_bib54","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.3748\/wjg.v21.i19.6026","article-title":"Association of type 2 diabetes mellitus and the risk of colorectal cancer: A meta-analysis and systematic review","volume":"21","author":"Guraya","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib55","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1463-1318.2012.02875.x","article-title":"Diabetes mellitus and the incidence and mortality of colorectal cancer: a meta-analysis of 24 cohort studies","volume":"14","author":"Luo","year":"2012","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.semcancer.2026.02.003_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102828","article-title":"Association of diabetes mellitus with early-onset colorectal cancer: A systematic review and meta-analysis of 19 studies including 10 million individuals and 30,000 events","volume":"17","author":"Khoa Ta","year":"2023","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.semcancer.2026.02.003_bib57","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/s41416-021-01347-4","article-title":"Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium","volume":"124","author":"Amadou","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib58","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ejca.2011.07.010","article-title":"Type 2 diabetes mellitus and colorectal cancer: meta-analysis on sex-specific differences","volume":"48","author":"Kr\u00e4mer","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib59","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00125-019-04995-7","article-title":"Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis","volume":"63","author":"Bhatia","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.semcancer.2026.02.003_bib60","doi-asserted-by":"crossref","first-page":"386","DOI":"10.15403\/jgld-5527","article-title":"Long-term risk of colorectal cancer in patients with prediabetes: a comprehensive systematic review and meta-analysis","volume":"33","author":"Keesari","year":"2024","journal-title":"J. Gastrointestin Liver Dis."},{"key":"10.1016\/j.semcancer.2026.02.003_bib61","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00125-014-3361-2","article-title":"Prediabetes and the risk of cancer: a meta-analysis","volume":"57","author":"Huang","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.semcancer.2026.02.003_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/srep17591","article-title":"A Linear Dose-response relationship between fasting plasma glucose and colorectal cancer risk: systematic review and meta-analysis","volume":"5","author":"Shi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.02.003_bib63","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6603932","article-title":"Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies","volume":"97","author":"Larsson","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib64","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.ejca.2012.02.063","article-title":"Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies","volume":"48","author":"Chen","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044522","article-title":"Excess body mass index and risk of liver cancer: a nonlinear dose-response meta-analysis of prospective studies","volume":"7","author":"Rui","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.02.003_bib66","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1634\/theoncologist.2012-0066","article-title":"Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies","volume":"17","author":"Wang","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.semcancer.2026.02.003_bib67","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/01635581.2019.1664602","article-title":"Excess Body Weight and the Risk of Liver Cancer: Systematic Review and a Meta-Analysis of Cohort Studies","volume":"72","author":"Yang","year":"2020","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3350\/cmh.2020.0176","article-title":"Obesity and the risk of primary liver cancer: A systematic review and meta-analysis","volume":"27","author":"Sohn","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2023.03.005","article-title":"Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose-response meta-analysis","volume":"185","author":"Yan","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib70","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.14.04067","article-title":"Role of body mass index and weight change in the risk of cancer: A systematic review and meta-analysis of 66 cohort studies","volume":"14","author":"Shi","year":"2024","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.semcancer.2026.02.003_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.111025","article-title":"Adipose distribution patterns as prognostic factors in patients with HCC: A systematic review and meta-analysis","volume":"167","author":"Shi","year":"2023","journal-title":"Eur. J. Radio."},{"key":"10.1016\/j.semcancer.2026.02.003_bib72","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/s41416-024-02857-7","article-title":"Association of metabolic obesity phenotypes with risk of overall and site-specific cancers: a systematic review and meta-analysis of cohort studies","volume":"131","author":"Mahamat-Saleh","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2023.112097","article-title":"Regional and sex differences in the mortality risk associated with primary liver cancer in obesity: A systematic review and meta-analysis","volume":"113","author":"Yang","year":"2023","journal-title":"Nutrition"},{"key":"10.1016\/j.semcancer.2026.02.003_bib74","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/07315724.2020.1751007","article-title":"Overweight and Obesity as Independent Factors for Increased Risk of Hepatocellular Cancer-Related Mortality: A Meta-Analysis","volume":"40","author":"Liu","year":"2021","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.semcancer.2026.02.003_bib75","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/COC.0000000000000388","article-title":"Obesity is Independently Associated With Increased Risk of Hepatocellular Cancer-related Mortality: A Systematic Review and Meta-Analysis","volume":"41","author":"Gupta","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib76","first-page":"356","article-title":"Is Higher BMI Associated with Worse Overall Mortality in Hepatocellular Carcinoma Patients? An Evidence Based Case Report","volume":"51","author":"Fahira","year":"2019","journal-title":"Acta Med Indones."},{"key":"10.1016\/j.semcancer.2026.02.003_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027326","article-title":"The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.02.003_bib78","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ijc.26165","article-title":"Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies","volume":"130","author":"Wang","year":"2012","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/CEJ.0000000000000038","article-title":"Effect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studies","volume":"24","author":"Chen","year":"2015","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib80","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.34965","article-title":"Diabetes is associated with increased liver cancer incidence and mortality in adults: a report from Asia Cohort Consortium","volume":"155","author":"Ho","year":"2024","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib81","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/07435800.2024.2361160","article-title":"Association between prediabetes and risk, mortality of hepatocellular carcinoma: a meta-analysis","volume":"49","author":"Ding","year":"2024","journal-title":"Endocr. Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib82","doi-asserted-by":"crossref","first-page":"185","DOI":"10.23736\/S0026-4806.16.04601-2","article-title":"The effect of prediabetes on hepatocellular carcinoma risk: a systematic review and meta-analysis","volume":"108","author":"Xu","year":"2017","journal-title":"Minerva Med"},{"key":"10.1016\/j.semcancer.2026.02.003_bib83","doi-asserted-by":"crossref","first-page":"50164","DOI":"10.18632\/oncotarget.16816","article-title":"Blood glucose concentration and risk of liver cancer: systematic review and meta-analysis of prospective studies","volume":"8","author":"Han","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.02.003_bib84","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12885-018-4351-4","article-title":"Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies","volume":"18","author":"Fang","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib85","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s00125-018-4664-5","article-title":"Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events","volume":"61","author":"Ohkuma","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.semcancer.2026.02.003_bib86","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.annepidem.2016.09.006","article-title":"Type 2 diabetes and gender differences in liver cancer by considering different confounding factors: a meta-analysis of cohort studies","volume":"26","author":"Wang","year":"2016","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib87","article-title":"Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.02.003_bib88","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1499-3872(11)60059-3","article-title":"Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis","volume":"10","author":"Wang","year":"2011","journal-title":"Hepatobiliary Pancreat. Dis. Int"},{"key":"10.1016\/j.semcancer.2026.02.003_bib89","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3325\/cmj.2022.63.176","article-title":"The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"63","author":"Mrzljak","year":"2022","journal-title":"Croat. Med J."},{"key":"10.1016\/j.semcancer.2026.02.003_bib90","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41395-018-0207-4","article-title":"Body mass index, diabetes and intrahepatic cholangiocarcinoma risk: the liver cancer pooling project and meta-analysis","volume":"113","author":"Petrick","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib92","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6603703","article-title":"Obesity and the risk of gallbladder cancer: a meta-analysis","volume":"96","author":"Larsson","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib93","doi-asserted-by":"crossref","first-page":"43669","DOI":"10.18632\/oncotarget.9664","article-title":"The association between BMI and gallbladder cancer risk: a meta-analysis","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.02.003_bib94","doi-asserted-by":"crossref","first-page":"146","DOI":"10.12659\/MSMBR.901651","article-title":"Body mass index can increase the risk of gallbladder cancer: a meta-analysis of 14 cohort studies","volume":"22","author":"Liu","year":"2016","journal-title":"Med Sci. Monit. Basic Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib95","article-title":"Integration of observational and causal evidence for the association between adiposity and 17 gastrointestinal outcomes: An umbrella review and meta-analysis","volume":"25","author":"Kim","year":"2024","journal-title":"Obes. Rev. J. Int Assoc. Study Obes."},{"key":"10.1016\/j.semcancer.2026.02.003_bib96","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.3390\/nu7105387","article-title":"Body Mass index and risk of gallbladder cancer: systematic review and meta-analysis of observational studies","volume":"7","author":"Tan","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2026.02.003_bib97","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/oby.21505","article-title":"Overweight, obesity and the risk of gallbladder and extrahepatic bile duct cancers: A meta-analysis of observational studies","volume":"24","author":"Li","year":"2016","journal-title":"Obes. (Silver Spring)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib98","doi-asserted-by":"crossref","DOI":"10.5402\/2013\/680536","article-title":"The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011","volume":"2013","author":"Dobbins","year":"2013","journal-title":"ISRN Prev. Med"},{"key":"10.1016\/j.semcancer.2026.02.003_bib99","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.semcancer.2026.02.003_bib100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/dmrr.2671","article-title":"Type 2 diabetes mellitus and risk of gallbladder cancer: a systematic review and meta-analysis of observational studies","volume":"32","author":"Gu","year":"2016","journal-title":"Diabetes Metab. Res Rev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib101","first-page":"837","article-title":"Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis","volume":"22","author":"Ren","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2026.02.003_bib102","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CEJ.0b013e3283481d89","article-title":"Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis","volume":"21","author":"Jing","year":"2012","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib103","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.bjc.6601140","article-title":"A meta-analysis of obesity and the risk of pancreatic cancer","volume":"89","author":"Berrington de Gonzalez","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib104","first-page":"1305","article-title":"Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts","volume":"21","author":"Jiao","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2026.02.003_bib105","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/annonc\/mdr398","article-title":"Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies","volume":"23","author":"Aune","year":"2012","journal-title":"Ann. Oncol. J. Eur. Soc. Med Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib106","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/ijc.22535","article-title":"Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies","volume":"120","author":"Larsson","year":"2007","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib107","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/jech-2017-208895","article-title":"Young adulthood and adulthood adiposity in relation to incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis","volume":"71","author":"Pang","year":"2017","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.semcancer.2026.02.003_bib108","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx012","article-title":"The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a mendelian randomization study","volume":"109","author":"Carreras-Torres","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2026.02.003_bib109","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/jgh.16477","article-title":"Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study","volume":"39","author":"Zhan","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1116582","article-title":"Correlation between pancreatic cancer and metabolic syndrome: A systematic review and meta-analysis","volume":"14","author":"Zhong","year":"2023","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib111","article-title":"Effect of Body Mass Index on Overall Survival of Pancreatic Cancer: A Meta-Analysis","volume":"95","author":"Shi","year":"2016","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.semcancer.2026.02.003_bib112","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cgh.2015.09.036","article-title":"Premorbid obesity and mortality in patients with pancreatic cancer: a systematic review and meta-analysis","volume":"14","author":"Majumder","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib113","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jama.1995.03520440059037","article-title":"Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis","volume":"273","author":"Everhart","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.semcancer.2026.02.003_bib114","first-page":"1928","article-title":"Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies","volume":"47","author":"Ben","year":"2011","journal-title":"Eur. J. Cancer Oxf. Engl. 1990"},{"key":"10.1016\/j.semcancer.2026.02.003_bib115","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","article-title":"Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies","volume":"92","author":"Huxley","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib116","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pcd.2018.11.015","article-title":"Diabetes mellitus and risk of pancreatic cancer in China: A meta-analysis based on 26 case-control studies","volume":"13","author":"Zhang","year":"2019","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.semcancer.2026.02.003_bib117","article-title":"Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis","volume":"10","author":"Song","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.semcancer.2026.02.003_bib118","doi-asserted-by":"crossref","first-page":"g7371","DOI":"10.1136\/bmj.g7371","article-title":"Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis","volume":"350","author":"Liao","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.semcancer.2026.02.003_bib119","article-title":"Prediabetes increases the risk of pancreatic cancer: A meta-analysis of longitudinal observational studies","volume":"19","author":"Huang","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.02.003_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/srep17102","article-title":"Effect of diabetes mellitus on survival in patients with pancreatic cancer: a systematic review and meta-analysis","volume":"5","author":"Mao","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.02.003_bib121","article-title":"Gastric cancer-Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: an updated review","volume":"41","author":"Mamun","year":"2024","journal-title":"Cancer Treat. Res Commun."},{"key":"10.1016\/j.semcancer.2026.02.003_bib122","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cac2.12220","article-title":"A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors","volume":"41","author":"Lu","year":"2021","journal-title":"Cancer Commun. Lond. Engl."},{"key":"10.1016\/j.semcancer.2026.02.003_bib123","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-024-03165-6","article-title":"Western diets and chronic diseases","volume":"30","author":"Adolph","year":"2024","journal-title":"Nat. Med"},{"key":"10.1016\/j.semcancer.2026.02.003_bib124","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.14.04205","article-title":"Global obesity epidemic and rising incidence of early-onset cancers","volume":"14","author":"Chen","year":"2024","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.semcancer.2026.02.003_bib125","article-title":"Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019","volume":"2","author":"Zhao","year":"2023","journal-title":"BMJ Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib126","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/nu16060800","article-title":"Healthy lifestyle and cancer risk: modifiable risk factors to prevent cancer","volume":"16","author":"Marino","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2026.02.003_bib127","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3390\/ijerph20043640","article-title":"The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress?","volume":"20","author":"Jardim","year":"2023","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.semcancer.2026.02.003_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.801228","article-title":"Dietary salt intake and gastric cancer risk: a systematic review and meta-analysis","volume":"8","author":"Wu","year":"2021","journal-title":"Front Nutr."},{"key":"10.1016\/j.semcancer.2026.02.003_bib129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41392-023-01376-w","article-title":"Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review","volume":"8","author":"Ruze","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.semcancer.2026.02.003_bib131","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13046-019-1309-6","article-title":"Effects of hyperglycemia on the progression of tumor diseases","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib132","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4093\/dmj.2014.38.5.330","article-title":"Hyperglycemia as a risk factor for cancer progression","volume":"38","author":"Ryu","year":"2014","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.semcancer.2026.02.003_bib133","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.02.003_bib134","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1111\/febs.14577","article-title":"Glucose transporters in cancer - from tumor cells to the tumor microenvironment","volume":"285","author":"Ancey","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.semcancer.2026.02.003_bib135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib136","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00432-009-0590-8","article-title":"Cancer's craving for sugar: an opportunity for clinical exploitation","volume":"135","author":"Yeluri","year":"2009","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib137","doi-asserted-by":"crossref","first-page":"68381","DOI":"10.18632\/oncotarget.20266","article-title":"SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.02.003_bib138","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12935-019-1075-8","article-title":"Hyperglycemia promotes Snail-induced epithelial-mesenchymal transition of gastric cancer via activating ENO1 expression","volume":"19","author":"Xu","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.semcancer.2026.02.003_bib139","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4161\/cbt.23786","article-title":"Excess glucose induces hypoxia-inducible factor-1\u03b1 in pancreatic cancer cells and stimulates glucose metabolism and cell migration","volume":"14","author":"Liu","year":"2013","journal-title":"Cancer Biol. Ther."},{"issue":"12","key":"10.1016\/j.semcancer.2026.02.003_bib140","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2174\/1871520619666190626120359","article-title":"Hypoxia-inducible Factor-1\u03b1 Mediates Hyperglycemia-induced Pancreatic Cancer Glycolysis","volume":"19","author":"Cheng","year":"2019","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.semcancer.2026.02.003_bib141","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-12-2796","article-title":"Acidity generated by the tumor microenvironment drives local invasion","volume":"73","author":"Estrella","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib142","first-page":"6517","article-title":"Pericellular pH affects distribution and secretion of cathepsin B in malignant cells","volume":"54","author":"Rozhin","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib143","first-page":"225","article-title":"On the Importance of Acidity in Cancer Cells and Therapy","volume":"13","author":"Tafech","year":"2024","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib144","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib145","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.02.003_bib146","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s12276-023-01153-3","article-title":"The polyol pathway and nuclear ketohexokinase A signaling drive hyperglycemia-induced metastasis of gastric cancer","volume":"56","author":"Kang","year":"2024","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.semcancer.2026.02.003_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.2","article-title":"Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway","volume":"6","author":"Vasconcelos-Dos-Santos","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.semcancer.2026.02.003_bib148","article-title":"Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib149","first-page":"1205","article-title":"Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells","volume":"50","author":"Hirata","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.semcancer.2026.02.003_bib150","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1073\/pnas.1113865109","article-title":"The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia","volume":"109","author":"Kang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2026.02.003_bib151","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12885-016-2213-5","article-title":"Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis","volume":"16","author":"Sakellariou","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib152","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2013.e36","article-title":"Knockdown of RAGE inhibits growth and invasion of gastric cancer cells","volume":"57","author":"Xu","year":"2013","journal-title":"Eur. J. Histochem"},{"key":"10.1016\/j.semcancer.2026.02.003_bib153","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1747326","article-title":"Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications","volume":"2022","author":"Yu","year":"2022","journal-title":"J. Diabetes Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib154","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcancer.2017.07.001","article-title":"AGEs, RAGEs and s-RAGE; friend or foe for cancer","volume":"49","author":"Ahmad","year":"2018","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12672-018-0342-9","article-title":"RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review","volume":"9","author":"Palanissami","year":"2018","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib156","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.3390\/ijms22158153","article-title":"Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer","volume":"22","author":"Taneja","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib157","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/cancers11091402","article-title":"Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality","volume":"11","author":"Ramteke","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib158","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.2174\/1871520621666210201095613","article-title":"Hyperglycemia Promotes Pancreatic Cancer Initiation and Progression by Activating the Wnt\/\u03b2-Catenin Signaling Pathway","volume":"21","author":"Chen","year":"2021","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.semcancer.2026.02.003_bib159","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.semcancer.2026.02.003_bib160","doi-asserted-by":"crossref","first-page":"24633","DOI":"10.1074\/jbc.274.35.24633","article-title":"Regulation of insulin-like growth factor-I and -II by glucose in primary cultures of fetal rat hepatocytes","volume":"274","author":"Goya","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2026.02.003_bib161","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3892\/mmr.2013.1339","article-title":"Changes in serum IGF-1 level and tumor VEGF expression in mice with colorectal cancer under hyperglycemic conditions","volume":"7","author":"Cao","year":"2013","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.semcancer.2026.02.003_bib162","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/2326-6066.CIR-19-0904","article-title":"Hyperglycemia Enhances Cancer Immune Evasion by Inducing Alternative Macrophage Polarization through Increased O-GlcNAcylation","volume":"8","author":"Rodrigues Mantuano","year":"2020","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib163","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.celrep.2017.11.010","article-title":"Hyperglycemia Impairs Neutrophil Mobilization Leading to Enhanced Metastatic Seeding","volume":"21","author":"Fainsod-Levi","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2026.02.003_bib164","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2337\/db21-0209","article-title":"Hyperglycemia and Not Hyperinsulinemia Mediates Diabetes-Induced Memory CD8 T-Cell Dysfunction","volume":"71","author":"Kavazovi\u0107","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.semcancer.2026.02.003_bib165","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-024-00743-1","article-title":"Macrophages and T cells in metabolic disorder-associated cancers","volume":"24","author":"Taranto","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib166","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/liv.12903","article-title":"Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma","volume":"35","author":"Chettouh","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.semcancer.2026.02.003_bib167","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.02.003_bib168","first-page":"191","article-title":"Insulin: a growth hormone and potential oncogene","volume":"17","author":"Laron","year":"2020","journal-title":"Pedia Endocrinol. Rev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib169","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4093\/dmj.2020.0250","article-title":"Hyperinsulinemia in obesity, inflammation, and cancer","volume":"45","author":"Zhang","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.semcancer.2026.02.003_bib170","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1210\/en.2005-1012","article-title":"Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo","volume":"147","author":"Tran","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcancer.2026.02.003_bib171","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jnci\/djt123","article-title":"Hyperglycemia, insulin resistance, impaired pancreatic \u03b2-cell function, and risk of pancreatic cancer","volume":"105","author":"Wolpin","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2026.02.003_bib172","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1158\/1940-6207.CAPR-16-0141","article-title":"Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes","volume":"9","author":"Loftfield","year":"2016","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib173","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/0284186X.2023.2197124","article-title":"Insulin resistance in patients with cancer: a systematic review and meta-analysis","volume":"62","author":"M\u00e0rmol","year":"2023","journal-title":"Acta Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib174","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fendo.2011.00093","article-title":"The insulin receptor: a new target for cancer therapy","volume":"2","author":"Malaguarnera","year":"2011","journal-title":"Front Endocrinol. (Lausanne"},{"key":"10.1016\/j.semcancer.2026.02.003_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1093257","article-title":"Obesity and endocrine-related cancer: The important role of IGF-1","volume":"14","author":"Zhong","year":"2023","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib176","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00125-009-1441-5","article-title":"Does diabetes therapy influence the risk of cancer?","volume":"52","author":"Smith","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.semcancer.2026.02.003_bib177","first-page":"6500","article-title":"Abnormal insulin-receptor down regulation and dissociation of down regulation from insulin biological action in cultured human tumor cells","volume":"47","author":"Mountjoy","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib178","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbrc.2023.01.061","article-title":"Insulin promotes the proliferation and migration of pancreatic cancer cells by up-regulating the expression of PLK1 through the PI3K\/AKT pathway","volume":"648","author":"Wu","year":"2023","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.semcancer.2026.02.003_bib179","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijms24032652","article-title":"The Role of PI3K\/AKT\/mTOR Signaling in Hepatocellular Carcinoma Metabolism","volume":"24","author":"Tian","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib180","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrc3967","article-title":"Adiposity and cancer risk: new mechanistic insights from epidemiology","volume":"15","author":"Renehan","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib181","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2337\/dc11-1833","article-title":"The association between IGF-I and insulin resistance: a general population study in Danish adults","volume":"35","author":"Friedrich","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semcancer.2026.02.003_bib182","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/biom11020217","article-title":"Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports","volume":"11","author":"Bailes","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.semcancer.2026.02.003_bib183","doi-asserted-by":"crossref","first-page":"29483","DOI":"10.1074\/jbc.271.46.29483","article-title":"Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma","volume":"271","author":"Warren","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2026.02.003_bib184","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13287-019-1319-5","article-title":"The role of insulin as a key regulator of seeding, proliferation, and mRNA transcription of human pluripotent stem cells","volume":"10","author":"Shahbazi","year":"2019","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.semcancer.2026.02.003_bib185","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1042\/BCJ20210134","article-title":"Insulin and cancer: a tangled web","volume":"479","author":"Leitner","year":"2022","journal-title":"Biochem J."},{"key":"10.1016\/j.semcancer.2026.02.003_bib186","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00592-011-0361-2","article-title":"Insulin resistance\/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up","volume":"49","author":"Perseghin","year":"2012","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib187","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13046-023-02850-7","article-title":"IGF-1R targeting in cancer \u2013 does sub-cellular localization matter?","volume":"42","author":"Soni","year":"2023","journal-title":"J. Exp. & Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.02.003_bib188","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1210\/endrev\/bnad015","article-title":"Update on Adipose Tissue and Cancer","volume":"44","author":"Brown","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib189","series-title":"Endocrine Changes in Obesity. [Updated 2022 Sep 6]","author":"Ylli","year":"2000"},{"key":"10.1016\/j.semcancer.2026.02.003_bib190","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/er.2010-0030","article-title":"Paracrine and endocrine effects of adipose tissue on cancer development and progression","volume":"32","author":"Park","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib191","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.semcancer.2026.02.003_bib192","first-page":"5673","article-title":"The roles of estrogen and estrogen receptors in gastrointestinal disease","volume":"18","author":"Chen","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.semcancer.2026.02.003_bib193","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.tem.2020.07.002","article-title":"The Sex Bias of Cancer","volume":"31","author":"Costa","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2026.02.003_bib194","doi-asserted-by":"crossref","first-page":"898","DOI":"10.20892\/j.issn.2095-3941.2024.0224","article-title":"Intricate roles of estrogen and estrogen receptors in digestive system cancers: a systematic review","volume":"21","author":"Gan","year":"2024","journal-title":"Cancer Biol. Med"},{"key":"10.1016\/j.semcancer.2026.02.003_bib195","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1210\/en.2011-0231","article-title":"Minireview: IGF, Insulin, and Cancer","volume":"152","author":"Gallagher","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcancer.2026.02.003_bib196","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/biomedicines12010097","article-title":"The Role of Adipokines in Tumor Progression and Its Association with Obesity","volume":"12","author":"Kim","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.semcancer.2026.02.003_bib197","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.3748\/wjg.v20.i18.5177","article-title":"Obesity and colorectal cancer: role of adipokines in tumor initiation and progression","volume":"20","author":"Riondino","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib198","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/ijc.23821","article-title":"Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways","volume":"123","author":"Jaffe","year":"2008","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib199","first-page":"3321","article-title":"Prognostic significance of serum adipokine levels in colorectal cancer patients","volume":"29","author":"Guadagni","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib200","doi-asserted-by":"crossref","first-page":"16120","DOI":"10.18632\/oncotarget.3878","article-title":"Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production","volume":"6","author":"Fan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.02.003_bib201","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-018-3319-7","article-title":"Adiponectin and colon cancer: evidence for inhibitory effects on viability and migration of human colorectal cell lines","volume":"448","author":"Nigro","year":"2018","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.semcancer.2026.02.003_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114186","article-title":"Globular adiponectin antagonizes leptin-induced growth of cancer cells by modulating inflammasomes activation: Critical role of HO-1 signaling","volume":"180","author":"Raut","year":"2020","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.semcancer.2026.02.003_bib203","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.mce.2013.08.013","article-title":"Adiponectin inhibits leptin-induced oncogenic signalling in oesophageal cancer cells by activation of PTP1B","volume":"382","author":"Beales","year":"2014","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib204","series-title":"Adipocytokines, Energy Balance, and Cancer [Internet]","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-41677-9_6","article-title":"Visfatin, Obesity, and Cancer","author":"Dalamaga","year":"2017"},{"key":"10.1016\/j.semcancer.2026.02.003_bib205","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.3390\/cancers14194656","article-title":"Apelin, a Circulating Biomarker in Cancer Evaluation: A Systematic Review","volume":"14","author":"Grinstead","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.02.003_bib206","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.3390\/ijms20153750","article-title":"Chemerin and Cancer","volume":"20","author":"Treeck","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib207","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3390\/ijms22115421","article-title":"Inflammation-Induced Tumorigenesis and Metastasis","volume":"22","author":"Hibino","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib208","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2026.02.003_bib209","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062188","article-title":"Low-grade inflammation in type 2 diabetes: a cross-sectional study from a Danish diabetes outpatient clinic","volume":"12","author":"Okdahl","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.semcancer.2026.02.003_bib210","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib211","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1017\/S0007114515002093","article-title":"Low-grade inflammation, diet composition and health: current research evidence and its translation","volume":"114","author":"Minihane","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.semcancer.2026.02.003_bib212","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70014","article-title":"Overview of oxidative stress and inflammation in diabetes","volume":"16","author":"Weinberg Sibony","year":"2024","journal-title":"J. Diabetes"},{"key":"10.1016\/j.semcancer.2026.02.003_bib213","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","article-title":"The inflammatory pathogenesis of colorectal cancer","volume":"21","author":"Schmitt","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib214","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1586\/17474124.2016.1103179","article-title":"The role of chronic inflammation in the development of gastrointestinal cancers: reviewing cancer prevention with natural anti-inflammatory intervention","volume":"10","author":"Lee","year":"2016","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib215","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41575-018-0054-1","article-title":"Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis","volume":"15","author":"Man","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib216","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/2394-4722.166994","article-title":"Chronic inflammation and gastrointestinal cancer","volume":"1","author":"Ida","year":"2015","journal-title":"J. Cancer Metastas.. Treat."},{"key":"10.1016\/j.semcancer.2026.02.003_bib217","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.02.003_bib218","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/cells5020015","article-title":"Roles of NF-\u03baB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches","volume":"5","author":"Park","year":"2016","journal-title":"Cells"},{"key":"10.1016\/j.semcancer.2026.02.003_bib219","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.693517","article-title":"Tumor-Associated Macrophages: A Potential Target for Cancer Therapy","volume":"11","author":"Tan","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib220","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.canlet.2020.10.029","article-title":"Macrophages in pancreatic cancer: An immunometabolic perspective","volume":"498","author":"Yang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2026.02.003_bib221","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.02.003_bib222","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib223","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s13046-019-1310-0","article-title":"IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma","volume":"38","author":"Wu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib224","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2013.09.031","article-title":"Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling","volume":"155","author":"He","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.02.003_bib225","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13046-019-1396-4","article-title":"From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma","volume":"38","author":"Fu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.semcancer.2026.02.003_bib226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem J."},{"key":"10.1016\/j.semcancer.2026.02.003_bib227","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-nutr-071715-050656","article-title":"Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus","volume":"36","author":"Koliaki","year":"2016","journal-title":"Annu Rev. Nutr. 2016\/05\/06 Ed."},{"key":"10.1016\/j.semcancer.2026.02.003_bib228","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1053\/j.gastro.2009.12.065","article-title":"The chromosomal instability pathway in colon cancer","volume":"138","author":"Pino","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2026.02.003_bib229","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.3390\/cancers13205037","article-title":"Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities","volume":"13","author":"Sorolla","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.02.003_bib230","doi-asserted-by":"crossref","first-page":"14890","DOI":"10.3390\/ijms232314890","article-title":"Mitochondrial Control in Inflammatory Gastrointestinal Diseases","volume":"23","author":"Sui","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib231","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6175804","article-title":"ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells","volume":"2019","author":"Snezhkina","year":"2019","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.semcancer.2026.02.003_bib232","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.105","article-title":"ROS homeostasis and metabolism: a dangerous liason in cancer cells","volume":"7","author":"Panieri","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcancer.2026.02.003_bib233","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/cells10051056","article-title":"Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation","volume":"10","author":"Schiliro","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.semcancer.2026.02.003_bib234","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12964-024-01490-4","article-title":"Mitochondrial dynamics and colorectal cancer biology: mechanisms and potential targets","volume":"22","author":"Wu","year":"2024","journal-title":"Cell Commun. Signal CCS"},{"key":"10.1016\/j.semcancer.2026.02.003_bib235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12967-023-03878-1","article-title":"Association of mitochondrial homeostasis and dynamic balance with malignant biological behaviors of gastrointestinal cancer","volume":"21","author":"Liu","year":"2023","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.semcancer.2026.02.003_bib236","doi-asserted-by":"crossref","first-page":"9715","DOI":"10.3390\/ijms25179715","article-title":"Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches","volume":"25","author":"Acevedo-Rom\u00e1n","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib237","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1224982","article-title":"Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes","volume":"10","author":"Patra","year":"2023","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib238","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/cancers17010090","article-title":"Effect of Gut Dysbiosis on Onset of GI Cancers","volume":"17","author":"Kumari","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib239","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.bbamem.2015.08.016","article-title":"Bacterial genotoxins: The long journey to the nucleus of mammalian cells","volume":"1858","author":"Frisan","year":"2016","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.semcancer.2026.02.003_bib240","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA a Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2026.02.003_bib241","doi-asserted-by":"crossref","unstructured":"Arya P.H., Vadhwana B., Tarazi M. Microbial dysbiosis in gastric cancer: association or causation? Best Practice & Research Clinical Gastroenterology. 2024;72:101961.","DOI":"10.1016\/j.bpg.2024.101961"},{"key":"10.1016\/j.semcancer.2026.02.003_bib242","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1073\/pnas.0506655103","article-title":"Molecular analysis of the bacterial microbiota in the human stomach","volume":"103","author":"Bik","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib243","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1053\/j.gastro.2007.06.056","article-title":"A New Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer","volume":"133","author":"Rhead","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2026.02.003_bib244","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3945\/ajcn.112.043885","article-title":"Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study","volume":"97","author":"Keszei","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.semcancer.2026.02.003_bib245","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5009\/gnl220260","article-title":"Microbial metabolite dysbiosis and colorectal cancer","volume":"17","author":"Niekamp","year":"2023","journal-title":"Gut Liver"},{"key":"10.1016\/j.semcancer.2026.02.003_bib246","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-micro-102215-095513","article-title":"Gut microbiota, inflammation, and colorectal cancer","volume":"70","author":"Brennan","year":"2016","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib247","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cid\/cir609","article-title":"Clinical importance of streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis","volume":"53","author":"Boleij","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.semcancer.2026.02.003_bib248","article-title":"The association of microbiome dysbiosis with colorectal cancer","volume":"14","author":"Artemev","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.semcancer.2026.02.003_bib249","article-title":"Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semcancer.2026.02.003_bib250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070803","article-title":"Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults","volume":"8","author":"Weir","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.02.003_bib251","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","article-title":"Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis","volume":"40","author":"Singh","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2026.02.003_bib252","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.mib.2014.11.013","article-title":"Fusobacterium nucleatum: a commensal-turned pathogen","volume":"23","author":"Han","year":"2015","journal-title":"Curr. Opin. Microbiol"},{"key":"10.1016\/j.semcancer.2026.02.003_bib253","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.semcancer.2026.02.003_bib254","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fonc.2018.00371","article-title":"Fusobacterium and Colorectal Cancer","volume":"8","author":"Zhou","year":"2018","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib255","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s42255-022-00558-0","article-title":"The gut microbial metabolite formate exacerbates colorectal cancer progression","volume":"4","author":"Ternes","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.semcancer.2026.02.003_bib256","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/nu13041189","article-title":"Targeting dietary and microbial Tryptophan-Indole metabolism as therapeutic approaches to colon cancer","volume":"13","author":"Wyatt","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2026.02.003_bib257","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.0906112107","article-title":"The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation","volume":"107","author":"Bansal","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib258","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.3748\/wjg.v26.i45.7173","article-title":"Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer","volume":"26","author":"Sun","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.02.003_bib259","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-020-01545-9","article-title":"Polyamines and related signaling pathways in cancer","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.semcancer.2026.02.003_bib260","first-page":"22","article-title":"Role of polyamines in immune cell functions","volume":"6","author":"Hesterberg","year":"2018","journal-title":"Med. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib261","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1080\/10408398.2020.1770199","article-title":"Novel findings of the association between gut microbiota\u2013derived metabolite trimethylamine N-oxide and inflammation: results from a systematic review and dose-response meta-analysis","volume":"60","author":"Farhangi","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.semcancer.2026.02.003_bib262","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gutjnl-2020-322753","article-title":"Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function","volume":"70","author":"Frost","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2026.02.003_bib263","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.tem.2024.06.003","article-title":"Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment","volume":"35","author":"Yu","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2026.02.003_bib264","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2020.01.002","article-title":"Gut microbiota: A new piece in understanding hepatocarcinogenesis","volume":"474","author":"Zhou","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2026.02.003_bib265","doi-asserted-by":"crossref","first-page":"e00153","DOI":"10.1128\/msystems.00153-20","article-title":"Alterations in the gut microbiome in the progression of cirrhosis to hepatocellular carcinoma","volume":"5","author":"Lapidot","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.semcancer.2026.02.003_bib266","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.1040991","article-title":"Dysbiosis: The first hit for digestive system cancer","volume":"13","author":"Mei","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib267","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.02.003_bib268","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","article-title":"A faecal microbiota signature with high specificity for pancreatic cancer","volume":"71","author":"Kartal","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2026.02.003_bib269","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.semcancer.2023.03.003","article-title":"\"Time\" for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment","volume":"91","author":"Miro","year":"2023","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib270","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2012.01.001","article-title":"Circadian rhythms and tumor growth","volume":"318","author":"Greene","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2026.02.003_bib271","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.3390\/ijms25115846","article-title":"The Relationship between Circadian Rhythm and Cancer Disease","volume":"25","author":"Munteanu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.02.003_bib272","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s43018-024-00759-4","article-title":"Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis","volume":"5","author":"Wang","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.semcancer.2026.02.003_bib273","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cell.2018.05.009","article-title":"Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR","volume":"174","author":"Walton","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.02.003_bib274","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1009064","article-title":"Circadian disruption and cancer- and treatment-related symptoms","volume":"12","author":"Amidi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib275","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.molmed.2024.09.001","article-title":"The trio of circadian clock, intestinal flora, and cancer","volume":"31","author":"Liu","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.semcancer.2026.02.003_bib276","article-title":"Circadian rhythm genes contribute to the prognosis prediction and potential therapeutic target in gastric cancer","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.02.003_bib277","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.975758","article-title":"Autophagy in gastrointestinal cancers","volume":"12","author":"Shao","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib278","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41574-018-0009-1","article-title":"Targeting autophagy in obesity: from pathophysiology to management","volume":"14","author":"Zhang","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib279","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.jdiacomp.2017.04.012","article-title":"Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?","volume":"31","author":"Yang","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.semcancer.2026.02.003_bib280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.canlet.2014.03.028","article-title":"Epidemiological-molecular evidence of metabolic reprogramming on proliferation, autophagy and cell signaling in pancreas cancer","volume":"356","author":"S\u00f8reide","year":"2015","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.semcancer.2026.02.003_bib281","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1440-1746.2011.07008.x","article-title":"Obesity, autophagy and the pathogenesis of liver and pancreatic cancers","volume":"27","author":"Aghajan","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib282","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3748\/wjg.v29.i2.286","article-title":"Screening and interventions to prevent nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis-associated hepatocellular carcinoma","volume":"29","author":"Cernea","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib283","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1634\/theoncologist.2011-0462","article-title":"Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis","volume":"17","author":"Soranna","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.semcancer.2026.02.003_bib284","article-title":"Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.02.003_bib285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis","volume":"7","author":"Noto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.02.003_bib286","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1940-6207.CAPR-13-0424","article-title":"Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders","volume":"7","author":"Gandini","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib287","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/dom.15509","article-title":"Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta-analysis","volume":"26","author":"Mesquita","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.semcancer.2026.02.003_bib288","article-title":"Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis","volume":"20","author":"Xie","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.02.003_bib289","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101781","article-title":"Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus","volume":"46","author":"Li","year":"2022","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib290","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/apt.17371","article-title":"Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin","volume":"57","author":"Zeng","year":"2023","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.semcancer.2026.02.003_bib291","article-title":"Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients","volume":"96","author":"Ma","year":"2017","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.semcancer.2026.02.003_bib292","first-page":"823","article-title":"Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer","volume":"29","author":"Murff","year":"2018","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2026.02.003_bib293","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canep.2012.12.009","article-title":"Association of metformin use with cancer incidence and mortality: a meta-analysis","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib294","article-title":"Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis","volume":"57","author":"Wang","year":"2025","journal-title":"Ann. Med"},{"key":"10.1016\/j.semcancer.2026.02.003_bib295","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12876-023-02671-0","article-title":"The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis","volume":"23","author":"Hu","year":"2023","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib296","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CAD.0000000000001254","article-title":"Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis","volume":"33","author":"Wang","year":"2022","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcancer.2026.02.003_bib297","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00384-020-03704-w","article-title":"Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis","volume":"35","author":"Yang","year":"2020","journal-title":"Int J. Colorectal Dis."},{"key":"10.1016\/j.semcancer.2026.02.003_bib298","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2337\/dci22-0047","article-title":"Metformin and Cancer: Solutions to a Real-World Evidence Failure","volume":"46","author":"Yu","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semcancer.2026.02.003_bib299","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/cld.568","article-title":"Statins and metformin for chemoprevention of hepatocellular carcinoma","volume":"8","author":"Choi","year":"2016","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib300","unstructured":"F.D.A. Drug Safety Communication: FDA Investigating Reports of Possible Increased Risk of Pancreatitis and Pre-Cancerous Findings of the Pancreas from Incretin Mimetic Drugs for Type 2 Diabetes. FDA. Available at: \u3008https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-investigating-reports-possible-increased-risk-pancreatitis-and-pre\u3009. (accessed on 16.03.2025)."},{"key":"10.1016\/j.semcancer.2026.02.003_bib301","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2026.02.003_bib302","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/dom.12291","article-title":"Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K\/Akt pathway","volume":"16","author":"Zhao","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.semcancer.2026.02.003_bib303","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fendo.2012.00158","article-title":"Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications","volume":"3","author":"K\u00f6rner","year":"2012","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib304","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12020-020-02223-6","article-title":"GLP-1 receptor agonists and pancreatic safety concerns in type 2 diabetic patients: data from cardiovascular outcome trials","volume":"68","author":"Cao","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.semcancer.2026.02.003_bib305","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/dom.12926","article-title":"Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials","volume":"19","author":"Monami","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.semcancer.2026.02.003_bib306","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/s41598-019-38956-2","article-title":"Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis","volume":"9","author":"Pinto","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.02.003_bib307","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.3390\/cancers16183224","article-title":"Risk of Esophageal and Gastric Cancer in Patients with Type 2 Diabetes Receiving Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A National Analysis","volume":"16","author":"Ayoub","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.02.003_bib308","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jamaoncol.2023.5573","article-title":"GLP-1 receptor Agonists and colorectal Cancer Risk in Drug-Naive patients with Type 2 Diabetes, with and without Overweight\/Obesity","volume":"10","author":"Wang","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.semcancer.2026.02.003_bib309","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.21305","article-title":"Glucagon-Like peptide 1 receptor agonists and 13 Obesity-Associated cancers in patients with type 2 diabetes","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.semcancer.2026.02.003_bib310","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107401","article-title":"Glucagon-Like peptide-1 receptor Agonists and Risk of Gastrointestinal Cancers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"208","author":"Figlioli","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.semcancer.2026.02.003_bib311","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2009-1272","article-title":"Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation","volume":"151","author":"Bjerre Knudsen","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcancer.2026.02.003_bib312","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejphar.2012.07.024","article-title":"Effect of exendin (exenatide)--GLP 1 receptor agonist on the thyroid and parathyroid gland in a rat model","volume":"691","author":"Bulchandani","year":"2012","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.semcancer.2026.02.003_bib313","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.927859","article-title":"Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials","volume":"13","author":"Hu","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2026.02.003_bib314","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2337\/dc22-1148","article-title":"GLP-1 Receptor Agonists and the Risk of Thyroid Cancer","volume":"46","author":"Bezin","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semcancer.2026.02.003_bib315","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/dc15-1816","article-title":"Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies","volume":"39","author":"Wu","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semcancer.2026.02.003_bib316","doi-asserted-by":"crossref","first-page":"8273","DOI":"10.1038\/s41598-017-07921-2","article-title":"Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.semcancer.2026.02.003_bib317","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1185\/03007995.2011.602964","article-title":"Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials","volume":"27","author":"Monami","year":"2011","journal-title":"Curr. Med Res Opin."},{"key":"10.1016\/j.semcancer.2026.02.003_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107981","article-title":"Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials","volume":"159","author":"Dicembrini","year":"2020","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.semcancer.2026.02.003_bib319","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-009-1418-4","article-title":"Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study","volume":"52","author":"Hemkens","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.semcancer.2026.02.003_bib320","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.numecd.2018.02.010","article-title":"Long-acting insulin analogs and cancer","volume":"28","author":"Sciacca","year":"2018","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"10.1016\/j.semcancer.2026.02.003_bib321","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051814","article-title":"Insulin glargine and cancer risk in patients with diabetes: a meta-analysis","volume":"7","author":"Tang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.02.003_bib322","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.5301\/JBM.2012.9349","article-title":"Insulin glargine and risk of cancer: a meta-analysis","volume":"27","author":"Du","year":"2012","journal-title":"Int J. Biol. Markers"},{"key":"10.1016\/j.semcancer.2026.02.003_bib323","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s00125-017-4370-8","article-title":"SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials","volume":"60","author":"Tang","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.semcancer.2026.02.003_bib324","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s40618-024-02351-0","article-title":"Sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis","volume":"47","author":"Xu","year":"2024","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.semcancer.2026.02.003_bib325","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/dom.13745","article-title":"Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials","volume":"21","author":"Dicembrini","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.semcancer.2026.02.003_bib326","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/pds.4943","article-title":"Pancreatic safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"29","author":"Tang","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.semcancer.2026.02.003_bib327","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177002","article-title":"Dapagliflozin suppressed gastric cancer growth via regulating OTUD5 mediated YAP1 deubiquitination","volume":"983","author":"Ren","year":"2024","journal-title":"Eur. J. Pharm."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X26000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X26000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:18:14Z","timestamp":1775517494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X26000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":327,"alternative-id":["S1044579X26000222"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.02.003","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity, type 2 diabetes and cancers of the digestive system","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}